Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)
van Herpen, C.M.L, Locati, L.D, Buter, J, Thomas, J, Bogaerts, J, Lacombe, D, de Mulder, P, Awada, A, Licitra, L, Bernier, J, Vermorken, J.B
Published in European journal of cancer (1990) (01.11.2008)
Published in European journal of cancer (1990) (01.11.2008)
Get full text
Journal Article
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review
Uijen, M.J.M., Lassche, G., van Engen-van Grunsven, A.C.H., Tada, Y., Verhaegh, G.W., Schalken, J.A., Driessen, C.M.L., van Herpen, C.M.L.
Published in Cancer treatment reviews (01.09.2020)
Published in Cancer treatment reviews (01.09.2020)
Get full text
Journal Article
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma
van Boxtel, W., Locati, L.D., van Engen-van Grunsven, A.C.H., Bergamini, C., Jonker, M.A., Fiets, E., Cavalieri, S., Tooten, S., Bos, E., Quattrone, P., Verhaegh, G.W., Schalken, J.A., Licitra, L., van Herpen, C.M.L.
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma
Uijen, M.J.M., Lassche, G., van Engen-van Grunsven, A.C.H., Driessen, C.M.L., van Herpen, C.M.L.
Published in Oral oncology (01.02.2022)
Published in Oral oncology (01.02.2022)
Get full text
Journal Article
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
Driessen, C.M.L, de Boer, J.P, Gelderblom, H, Rasch, C.R.N, de Jong, M.A, Verbist, B.M, Melchers, W.J.G, Tesselaar, M.E.T, van der Graaf, W.T.A, Kaanders, J.H.A.M, van Herpen, C.M.L
Published in European journal of cancer (1990) (01.01.2016)
Published in European journal of cancer (1990) (01.01.2016)
Get full text
Journal Article
Reply letter to: Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participant – Reply to Füssenich et al.: A new, simple and objective prognostic score for phase I cancer patients
van Herpen, C.M.L, Teerenstra, S, Desar, I.M.E, van der Graaf, W.T.A
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article
Cetuximab-induced pneumonitis in head and neck cancer patient
De Vos, F.Y.F.L, Driessen, C.M.L, Jaspers, H.C.J, van Herpen, C.M.L, Simons, B
Published in Oral oncology (01.06.2012)
Published in Oral oncology (01.06.2012)
Get full text
Journal Article
P103 Radiation dermatitis in patients receiving radiotherapy with concurrent cetuximab for treatment of head and neck cancer. A new challenge in nursing care
van Opstal, C, Lintz-Luidens, H, Janssens, G.O.R.J, van Herpen, C.M.L
Published in European journal of oncology nursing : the official journal of European Oncology Nursing Society (2010)
Published in European journal of oncology nursing : the official journal of European Oncology Nursing Society (2010)
Get full text
Journal Article
911P Case series of docetaxel, trastuzumab, and pertuzumab (DTP) and subsequent ado-trastuzumab emtansine (T-DM1) for recurrent or metastatic (R/M) HER2-positive salivary duct carcinoma (SDC)
Uijen, M., Lassche, G., van Engen-van Grunsven, A., Driessen, C., Van Herpen, C.M.L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
van der Velden, D L, Hoes, L R, van der Wijngaart, H, van Berge Henegouwen, J M, van Werkhoven, E, Roepman, P, Schilsky, R L, de Leng, W W J, Huitema, A D R, Nuijen, B, Nederlof, P M, van Herpen, C M L, de Groot, D J A, Devriese, L A, Hoeben, A, de Jonge, M J A, Chalabi, M, Smit, E F, de Langen, A J, Mehra, N, Labots, M, Kapiteijn, E, Sleijfer, S, Cuppen, E, Verheul, H M W, Gelderblom, H, Voest, E E
Published in Nature (London) (01.10.2019)
Published in Nature (London) (01.10.2019)
Get full text
Journal Article
904P Retrospective analysis of adjuvant systemic anti-hormonal therapy for resected androgen receptor-positive (AR+) salivary duct carcinoma (SDC)
Weijers, J.A.M., Verhaegh, G.W., Driessen, C.M.L., Engen-van Grunsven, I.V., Devriese, L.A., Slingerland, M., Hoeben, A., Schalken, J.A., Van Herpen, C.M.L.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
659 A novel mechanism of action of platinum-drugs: breaking STAT6-mediated suppression of immune responses against cancer
Lesterhuis, W, Punt, C.J.A, Eleveld-Trancikova, D, Jansen, B.J.H, Van Herpen, C.M.L, Kaanders, J.H, Van Krieken, J.H.J.M, Adema, G.J, Figdor, C.G, De Vries, I.J.M
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
1104 Immunological response to influenza vaccine in cancer patients undergoing treatment with sunitinib or sorafenib
Mulder, S.F, Jacobs, J.F.M, Nordkamp, M.A.M. Olde, Kremer, I.K, Mulders, P.F.A, Punt, C.J.A, de Vries, I.J.M, van Herpen, C.M.L
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
408 POSTER Phase 1 study of recombinant human Interleukin-21 (rIL-21) in combination with sunitinib in patients with stage IV renal cell carcinoma
Grünwald, V, Desar, I, Haanen, J, Fiedler, W, Olsen, M.B, van Herpen, C.M.L
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Molecular Tumor Boards: current practice and future needs
van der Velden, D.L., van Herpen, C.M.L., van Laarhoven, H.W.M., Smit, E.F., Groen, H.J.M., Willems, S.M., Nederlof, P.M., Langenberg, M.H.G., Cuppen, E., Sleijfer, S., Steeghs, N., Voest, E.E.
Published in Annals of oncology (01.12.2017)
Published in Annals of oncology (01.12.2017)
Get full text
Journal Article
SP-0625: Merkel cell carcinoma: an oncologic emergency
Kaanders, J., Zwijnenburg, E.M., Takes, R.P., Weijs, W.L.J., Werner, J.E.M., Van Herpen, C.M.L., Adema, G.J., Lubeek, S.F.K.
Published in Radiotherapy and oncology (01.11.2020)
Published in Radiotherapy and oncology (01.11.2020)
Get full text
Journal Article
1081 The effect of sorafenib on Indium-111 labeled bevacizumab uptake in patients with clear cell renal cell carcinoma (ccRCC)
Desar, I.M.E, Stillebroer, A.B, Oosterwijk, E, Leenders, W.P.J, van Herpen, C.M.L, van der Graaf, W.T.A, Boerman, O.C, Oyen, W.J.G, Mulders, P.F.A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article